V. Payne, N. Grimsey, A. Tuthill, S. Virtue, S. Gray et al., The Human Lipodystrophy Gene BSCL2/Seipin May Be Essential for Normal Adipocyte Differentiation, Diabetes, vol.57, issue.8, pp.2055-60, 2008.
DOI : 10.2337/db08-0184

W. Chen, V. Yechoor, B. Chang, M. Li, and K. March, The Human Lipodystrophy Gene Product Berardinelli-Seip Congenital Lipodystrophy 2/Seipin Plays a Key Role in Adipocyte Differentiation, Endocrinology, vol.150, issue.10, pp.4552-61, 2009.
DOI : 10.1210/en.2009-0236

C. Kim, M. Delepine, E. Boutet, E. Mourabit, H. et al., Association of a Homozygous Nonsense Caveolin-1 Mutation with Berardinelli-Seip Congenital Lipodystrophy, The Journal of Clinical Endocrinology & Metabolism, vol.93, issue.4, pp.1129-1163, 2008.
DOI : 10.1210/jc.2007-1328

E. Boutet, E. Mourabit, H. Prot, M. Nemani, M. Khallouf et al., Seipin deficiency alters fatty acid ??9 desaturation and lipid droplet formation in Berardinelli-Seip congenital lipodystrophy, Biochimie, vol.91, issue.6, pp.796-803, 2009.
DOI : 10.1016/j.biochi.2009.01.011

Y. Hayashi, C. Matsuda, M. Ogawa, K. Goto, K. Tominaga et al., Human PTRF mutations cause secondary deficiency of caveolins resulting in muscular dystrophy with generalized lipodystrophy, Journal of Clinical Investigation, vol.119, issue.9, pp.2623-2656, 2009.
DOI : 10.1172/JCI38660DS1

J. Flier, D. Moller, A. Moses, O. Rahilly, S. Chaiken et al., Insulin-mediated pseudoacromegaly: clinical and biochemical characterization of a syndrome of selective insulin resistance, J Clin Endocrinol Metab, vol.76, pp.1533-1574, 1993.

R. Semple, A. Sleigh, P. Murgatroyd, C. Adams, L. Bluck et al., Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis, Journal of Clinical Investigation, vol.119, pp.315-337, 2009.
DOI : 10.1172/JCI37432DS1

M. Goodarzi, M. Jones, Y. Chen, and R. Azziz, First Evidence of Genetic Association Between AKT2 and Polycystic Ovary Syndrome, Diabetes Care, vol.31, issue.12, pp.2284-2291, 2008.
DOI : 10.2337/dc08-0532

A. Dunaif, Insulin resistance in women with polycystic ovary syndrome, Fertility and Sterility, vol.86, issue.1, pp.13-17, 2006.
DOI : 10.1016/j.fertnstert.2006.04.011

E. Diamanti-kandarakis and A. Papavassiliou, Molecular mechanisms of insulin resistance in polycystic ovary syndrome, Trends in Molecular Medicine, vol.12, issue.7, pp.324-356, 2006.
DOI : 10.1016/j.molmed.2006.05.006

C. Musso, T. Shawker, E. Cochran, E. Javor, J. Young et al., Clinical evidence that hyperinsulinaemia independent of gonadotropins stimulates ovarian growth, Clinical Endocrinology, vol.15, issue.1, pp.73-81, 2005.
DOI : 10.1210/jc.86.12.5925

A. Vambergue, C. Lautier, A. Valat, C. Cortet-rudelli, F. Grigorescu et al., Follow-up study of two sisters with type A syndrome of severe insulin resistance gives a new insight into PCOS pathogenesis in relation to puberty and pregnancy outcome: a case report, Human Reproduction, vol.21, issue.5, pp.1274-1282, 2006.
DOI : 10.1093/humrep/dei455

E. Oral, E. Ruiz, A. Andewelt, N. Sebring, A. Wagner et al., Effect of Leptin Replacement on Pituitary Hormone Regulation in Patients with Severe Lipodystrophy, The Journal of Clinical Endocrinology & Metabolism, vol.87, issue.7, pp.3110-3117, 2002.
DOI : 10.1210/jcem.87.7.8591

C. Musso, E. Cochran, E. Javor, J. Young, A. Depaoli et al., The long-term effect of recombinant methionyl human leptin therapy on hyperandrogenism and menstrual function in female and pituitary function in male and female hypoleptinemic lipodystrophic patients, Metabolism, vol.54, issue.2, pp.255-63, 2005.
DOI : 10.1016/j.metabol.2004.08.021

J. Beltrand, M. Beregszaszi, D. Chevenne, G. Sebag, D. Kerdanet et al., Metabolic Correction Induced by Leptin Replacement Treatment in Young Children With Berardinelli-Seip Congenital Lipoatrophy, PEDIATRICS, vol.120, issue.2, pp.291-297, 2007.
DOI : 10.1542/peds.2006-3165

R. Semple, M. Soos, J. Luan, C. Mitchell, J. Wilson et al., Elevated Plasma Adiponectin in Humans with Genetically Defective Insulin Receptors, The Journal of Clinical Endocrinology & Metabolism, vol.91, issue.8, pp.3219-3242, 2006.
DOI : 10.1210/jc.2006-0166

R. Semple, E. Cochran, M. Soos, K. Burling, D. Savage et al., Plasma Adiponectin as a Marker of Insulin Receptor Dysfunction: Clinical utility in severe insulin resistance, Diabetes Care, vol.31, issue.5, pp.977-986, 2008.
DOI : 10.2337/dc07-2194

F. Andreelli, H. Hanaire-broutin, M. Laville, J. Tauber, J. Riou et al., Normal Reproductive Function in Leptin-Deficient Patients with Lipoatropic Diabetes, The Journal of Clinical Endocrinology & Metabolism, vol.85, issue.2, pp.715-724, 2000.
DOI : 10.1210/jcem.85.2.6392

S. Johnsen, S. Dolan, K. Fitch, K. Killilea, J. Shifren et al., Absence of Polycystic Ovary Syndrome Features in Human Immunodeficiency Virus-Infected Women Despite Significant Hyperinsulinemia and Truncal Adiposity, The Journal of Clinical Endocrinology & Metabolism, vol.90, issue.10, pp.5596-604, 2005.
DOI : 10.1210/jc.2005-1083

A. Decaudain, M. Vantyghem, B. Guerci, A. Hecart, M. Auclair et al., Mutations in Patients with Severe Metabolic Syndrome, The Journal of Clinical Endocrinology & Metabolism, vol.92, issue.12, pp.4835-4879, 2007.
DOI : 10.1210/jc.2007-0654

J. Keller, L. Subramanyam, V. Simha, R. Gustofson, D. Minjarez et al., Lipodystrophy, Obstetrics & Gynecology, vol.114, issue.Supplement, pp.427-458, 2009.
DOI : 10.1097/AOG.0b013e31819feaa9

J. Young, L. Morbois-trabut, B. Couzinet, O. Lascols, E. Dion et al., Type A Insulin Resistance Syndrome Revealing a Novel Lamin A Mutation, Diabetes, vol.54, issue.6, pp.1873-1881, 2005.
DOI : 10.2337/diabetes.54.6.1873